CA2545899A1 - Proteome epitope tags and methods of use thereof in protein modification analysis - Google Patents

Info

Publication number

CA2545899A1

CA2545899A1 CA002545899A CA2545899A CA2545899A1 CA 2545899 A1 CA2545899 A1 CA 2545899A1 CA 002545899 A CA002545899 A CA 002545899A CA 2545899 A CA2545899 A CA 2545899A CA 2545899 A1 CA2545899 A1 CA 2545899A1

Authority

CA

Canada

Prior art keywords

pet

protein

proteins

sample

array

Prior art date

2003-11-13

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 329
• 108010026552 Proteome Proteins 0.000 title claims abstract description 67
• 238000004458 analytical method Methods 0.000 title claims description 31
• 230000009145 protein modification Effects 0.000 title description 7
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 560
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 552
• 238000003491 array Methods 0.000 claims abstract description 46
• 230000026731 phosphorylation Effects 0.000 claims abstract description 38
• 238000006366 phosphorylation reaction Methods 0.000 claims abstract description 38
• 230000013595 glycosylation Effects 0.000 claims abstract description 15
• 238000006206 glycosylation reaction Methods 0.000 claims abstract description 15
• 230000021736 acetylation Effects 0.000 claims abstract description 7
• 238000006640 acetylation reaction Methods 0.000 claims abstract description 7
• 230000011987 methylation Effects 0.000 claims abstract description 7
• 238000007069 methylation reaction Methods 0.000 claims abstract description 7
• 239000003795 chemical substances by application Substances 0.000 claims description 447
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 176
• 239000012634 fragment Substances 0.000 claims description 110
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 106
• 238000009739 binding Methods 0.000 claims description 104
• 238000001514 detection method Methods 0.000 claims description 103
• 230000027455 binding Effects 0.000 claims description 102
• 210000004027 cell Anatomy 0.000 claims description 89
• 230000004481 post-translational protein modification Effects 0.000 claims description 75
• 239000000758 substrate Substances 0.000 claims description 67
• 238000003556 assay Methods 0.000 claims description 62
• 239000012530 fluid Substances 0.000 claims description 60
• 239000004365 Protease Substances 0.000 claims description 54
• 238000004925 denaturation Methods 0.000 claims description 51
• 102000035195 Peptidases Human genes 0.000 claims description 50
• 108091005804 Peptidases Proteins 0.000 claims description 50
• 239000000427 antigen Substances 0.000 claims description 50
• 108091007433 antigens Proteins 0.000 claims description 49
• 102000036639 antigens Human genes 0.000 claims description 49
• 239000011324 bead Substances 0.000 claims description 49
• 239000002096 quantum dot Substances 0.000 claims description 49
• 230000019491 signal transduction Effects 0.000 claims description 49
• 150000001413 amino acids Chemical group 0.000 claims description 48
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 48
• 238000011282 treatment Methods 0.000 claims description 47
• 102000004190 Enzymes Human genes 0.000 claims description 44
• 108090000790 Enzymes Proteins 0.000 claims description 44
• 229940088598 enzyme Drugs 0.000 claims description 44
• 230000029087 digestion Effects 0.000 claims description 40
• 239000000203 mixture Substances 0.000 claims description 40
• 201000010099 disease Diseases 0.000 claims description 39
• 239000000463 material Substances 0.000 claims description 37
• 102000007079 Peptide Fragments Human genes 0.000 claims description 36
• 108010033276 Peptide Fragments Proteins 0.000 claims description 36
• 230000003993 interaction Effects 0.000 claims description 36
• 235000019419 proteases Nutrition 0.000 claims description 35
• 210000002966 serum Anatomy 0.000 claims description 35
• -1 gluc-C Proteins 0.000 claims description 34
• 150000001875 compounds Chemical class 0.000 claims description 32
• 230000037361 pathway Effects 0.000 claims description 32
• 238000013467 fragmentation Methods 0.000 claims description 28
• 238000006062 fragmentation reaction Methods 0.000 claims description 28
• 229920001184 polypeptide Polymers 0.000 claims description 28
• 241000282414 Homo sapiens Species 0.000 claims description 27
• 241001465754 Metazoa Species 0.000 claims description 27
• 108090000631 Trypsin Proteins 0.000 claims description 25
• 102000004142 Trypsin Human genes 0.000 claims description 25
• 230000036425 denaturation Effects 0.000 claims description 25
• 239000007787 solid Substances 0.000 claims description 25
• 239000003814 drug Substances 0.000 claims description 24
• 230000035945 sensitivity Effects 0.000 claims description 23
• 239000012588 trypsin Substances 0.000 claims description 23
• 229960001322 trypsin Drugs 0.000 claims description 23
• 229940079593 drug Drugs 0.000 claims description 22
• 230000002163 immunogen Effects 0.000 claims description 22
• 210000002381 plasma Anatomy 0.000 claims description 21
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims description 21
• 229920000642 polymer Polymers 0.000 claims description 20
• 108091023037 Aptamer Proteins 0.000 claims description 19
• 239000000975 dye Substances 0.000 claims description 19
• 241000894007 species Species 0.000 claims description 19
• 210000004369 blood Anatomy 0.000 claims description 18
• 239000008280 blood Substances 0.000 claims description 18
• 230000008859 change Effects 0.000 claims description 18
• 230000000694 effects Effects 0.000 claims description 17
• 238000002965 ELISA Methods 0.000 claims description 16
• 108091000080 Phosphotransferase Proteins 0.000 claims description 16
• 150000007523 nucleic acids Chemical class 0.000 claims description 16
• 102000020233 phosphotransferase Human genes 0.000 claims description 16
• 238000002360 preparation method Methods 0.000 claims description 16
• 239000012528 membrane Substances 0.000 claims description 15
• 102000039446 nucleic acids Human genes 0.000 claims description 15
• 108020004707 nucleic acids Proteins 0.000 claims description 15
• 230000004913 activation Effects 0.000 claims description 14
• 238000003508 chemical denaturation Methods 0.000 claims description 14
• 210000002700 urine Anatomy 0.000 claims description 14
• 239000003550 marker Substances 0.000 claims description 13
• 239000002245 particle Substances 0.000 claims description 13
• 238000005194 fractionation Methods 0.000 claims description 12
• 238000004519 manufacturing process Methods 0.000 claims description 12
• 230000017854 proteolysis Effects 0.000 claims description 12
• 230000000638 stimulation Effects 0.000 claims description 12
• 210000004381 amniotic fluid Anatomy 0.000 claims description 11
• 210000001124 body fluid Anatomy 0.000 claims description 11
• 230000005764 inhibitory process Effects 0.000 claims description 11
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 10
• 102000004127 Cytokines Human genes 0.000 claims description 10
• 108090000695 Cytokines Proteins 0.000 claims description 10
• 108020004414 DNA Proteins 0.000 claims description 10
• 108091093037 Peptide nucleic acid Proteins 0.000 claims description 10
• 239000010839 body fluid Substances 0.000 claims description 10
• 238000000605 extraction Methods 0.000 claims description 10
• 239000007850 fluorescent dye Substances 0.000 claims description 10
• 210000003296 saliva Anatomy 0.000 claims description 10
• 238000012216 screening Methods 0.000 claims description 10
• 230000028327 secretion Effects 0.000 claims description 10
• 239000002904 solvent Substances 0.000 claims description 10
• 239000006228 supernatant Substances 0.000 claims description 10
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 9
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 9
• 210000003567 ascitic fluid Anatomy 0.000 claims description 9
• 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 9
• 238000003745 diagnosis Methods 0.000 claims description 9
• 230000002496 gastric effect Effects 0.000 claims description 9
• 239000002773 nucleotide Substances 0.000 claims description 9
• 125000003729 nucleotide group Chemical group 0.000 claims description 9
• 238000011160 research Methods 0.000 claims description 9
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims description 8
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims description 8
• 208000005228 Pericardial Effusion Diseases 0.000 claims description 8
• 230000001413 cellular effect Effects 0.000 claims description 8
• 210000002726 cyst fluid Anatomy 0.000 claims description 8
• 239000000284 extract Substances 0.000 claims description 8
• 210000004392 genitalia Anatomy 0.000 claims description 8
• 238000000338 in vitro Methods 0.000 claims description 8
• 210000004072 lung Anatomy 0.000 claims description 8
• 230000001926 lymphatic effect Effects 0.000 claims description 8
• 210000004912 pericardial fluid Anatomy 0.000 claims description 8
• 238000002331 protein detection Methods 0.000 claims description 8
• 102000005962 receptors Human genes 0.000 claims description 8
• 108020003175 receptors Proteins 0.000 claims description 8
• 150000003384 small molecules Chemical class 0.000 claims description 8
• 210000001179 synovial fluid Anatomy 0.000 claims description 8
• 239000012130 whole-cell lysate Substances 0.000 claims description 8
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 claims description 7
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 claims description 7
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 7
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 7
• 108090000526 Papain Proteins 0.000 claims description 7
• 108090000284 Pepsin A Proteins 0.000 claims description 7
• 102000057297 Pepsin A Human genes 0.000 claims description 7
• 230000003187 abdominal effect Effects 0.000 claims description 7
• 230000009089 cytolysis Effects 0.000 claims description 7
• 230000002550 fecal effect Effects 0.000 claims description 7
• 210000004907 gland Anatomy 0.000 claims description 7
• 230000003100 immobilizing effect Effects 0.000 claims description 7
• 229940055729 papain Drugs 0.000 claims description 7
• 235000019834 papain Nutrition 0.000 claims description 7
• 229940111202 pepsin Drugs 0.000 claims description 7
• 210000004910 pleural fluid Anatomy 0.000 claims description 7
• 238000000527 sonication Methods 0.000 claims description 7
• 210000004243 sweat Anatomy 0.000 claims description 7
• 230000034512 ubiquitination Effects 0.000 claims description 7
• 238000010798 ubiquitination Methods 0.000 claims description 7
• 241000219195 Arabidopsis thaliana Species 0.000 claims description 6
• 108010032088 Calpain Proteins 0.000 claims description 6
• 102000007590 Calpain Human genes 0.000 claims description 6
• 108010006303 Carboxypeptidases Proteins 0.000 claims description 6
• 102000005367 Carboxypeptidases Human genes 0.000 claims description 6
• 108090000317 Chymotrypsin Proteins 0.000 claims description 6
• 241000196324 Embryophyta Species 0.000 claims description 6
• 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 6
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 6
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 6
• 101001018085 Lysobacter enzymogenes Lysyl endopeptidase Proteins 0.000 claims description 6
• 108090000787 Subtilisin Proteins 0.000 claims description 6
• 150000001720 carbohydrates Chemical class 0.000 claims description 6
• 239000013043 chemical agent Substances 0.000 claims description 6
• 229960002376 chymotrypsin Drugs 0.000 claims description 6
• 238000009472 formulation Methods 0.000 claims description 6
• 230000003053 immunization Effects 0.000 claims description 6
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
• 230000013823 prenylation Effects 0.000 claims description 6
• 238000012545 processing Methods 0.000 claims description 6
• 238000011084 recovery Methods 0.000 claims description 6
• 230000004044 response Effects 0.000 claims description 6
• 238000010008 shearing Methods 0.000 claims description 6
• 241000255601 Drosophila melanogaster Species 0.000 claims description 5
• 108010067770 Endopeptidase K Proteins 0.000 claims description 5
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 5
• 241000244206 Nematoda Species 0.000 claims description 5
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
• 230000009435 amidation Effects 0.000 claims description 5
• 238000007112 amidation reaction Methods 0.000 claims description 5
• 230000001580 bacterial effect Effects 0.000 claims description 5
• 235000014633 carbohydrates Nutrition 0.000 claims description 5
• 238000012875 competitive assay Methods 0.000 claims description 5
• 230000022244 formylation Effects 0.000 claims description 5
• 238000006170 formylation reaction Methods 0.000 claims description 5
• 230000033444 hydroxylation Effects 0.000 claims description 5
• 238000005805 hydroxylation reaction Methods 0.000 claims description 5
• 239000012678 infectious agent Substances 0.000 claims description 5
• 230000007498 myristoylation Effects 0.000 claims description 5
• 238000011002 quantification Methods 0.000 claims description 5
• 235000000346 sugar Nutrition 0.000 claims description 5
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 5
• 230000003612 virological effect Effects 0.000 claims description 5
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 4
• ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 claims description 4
• 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 claims description 4
• 241000251468 Actinopterygii Species 0.000 claims description 4
• 108091035707 Consensus sequence Proteins 0.000 claims description 4
• 241000252212 Danio rerio Species 0.000 claims description 4
• 102000014150 Interferons Human genes 0.000 claims description 4
• 108010050904 Interferons Proteins 0.000 claims description 4
• 108090001090 Lectins Proteins 0.000 claims description 4
• 102000004856 Lectins Human genes 0.000 claims description 4
• 102000043136 MAP kinase family Human genes 0.000 claims description 4
• 108091054455 MAP kinase family Proteins 0.000 claims description 4
• 241001529936 Murinae Species 0.000 claims description 4
• 241000315672 SARS coronavirus Species 0.000 claims description 4
• 241000235343 Saccharomycetales Species 0.000 claims description 4
• 241000235347 Schizosaccharomyces pombe Species 0.000 claims description 4
• 241000269370 Xenopus <genus> Species 0.000 claims description 4
• 239000002671 adjuvant Substances 0.000 claims description 4
• 239000000556 agonist Substances 0.000 claims description 4
• 230000006240 deamidation Effects 0.000 claims description 4
• 239000002158 endotoxin Substances 0.000 claims description 4
• 230000004992 fission Effects 0.000 claims description 4
• 229940079322 interferon Drugs 0.000 claims description 4
• ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 claims description 4
• 239000002523 lectin Substances 0.000 claims description 4
• 229920006008 lipopolysaccharide Polymers 0.000 claims description 4
• BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 claims description 4
• 238000004806 packaging method and process Methods 0.000 claims description 4
• 230000002285 radioactive effect Effects 0.000 claims description 4
• 238000012827 research and development Methods 0.000 claims description 4
• 239000011669 selenium Substances 0.000 claims description 4
• 230000035939 shock Effects 0.000 claims description 4
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 claims description 3
• 229910052693 Europium Inorganic materials 0.000 claims description 3
• 102000004877 Insulin Human genes 0.000 claims description 3
• 108090001061 Insulin Proteins 0.000 claims description 3
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
• BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
• 239000004473 Threonine Substances 0.000 claims description 3
• 239000002253 acid Substances 0.000 claims description 3
• 125000003636 chemical group Chemical group 0.000 claims description 3
• 239000000412 dendrimer Substances 0.000 claims description 3
• 229920000736 dendritic polymer Polymers 0.000 claims description 3
• OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 claims description 3
• 230000012010 growth Effects 0.000 claims description 3
• 230000028993 immune response Effects 0.000 claims description 3
• 238000003364 immunohistochemistry Methods 0.000 claims description 3
• 229940125396 insulin Drugs 0.000 claims description 3
• 239000004816 latex Substances 0.000 claims description 3
• 229920000126 latex Polymers 0.000 claims description 3
• 150000002632 lipids Chemical class 0.000 claims description 3
• 239000002105 nanoparticle Substances 0.000 claims description 3
• 230000002018 overexpression Effects 0.000 claims description 3
• 229910052711 selenium Inorganic materials 0.000 claims description 3
• 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 claims description 2
• 102000019260 B-Cell Antigen Receptors Human genes 0.000 claims description 2
• 108010012919 B-Cell Antigen Receptors Proteins 0.000 claims description 2
• 208000035143 Bacterial infection Diseases 0.000 claims description 2
• 108010071942 Colony-Stimulating Factors Proteins 0.000 claims description 2
• 102000007644 Colony-Stimulating Factors Human genes 0.000 claims description 2
• 241000168726 Dictyostelium discoideum Species 0.000 claims description 2
• 108091006027 G proteins Proteins 0.000 claims description 2
• 102000030782 GTP binding Human genes 0.000 claims description 2
• 108091000058 GTP-Binding Proteins 0.000 claims description 2
• 229920001503 Glucan Polymers 0.000 claims description 2
• 108090000978 Interleukin-4 Proteins 0.000 claims description 2
• 102000015696 Interleukins Human genes 0.000 claims description 2
• 108010063738 Interleukins Proteins 0.000 claims description 2
• 230000004163 JAK-STAT signaling pathway Effects 0.000 claims description 2
• 102100023482 Mitogen-activated protein kinase 14 Human genes 0.000 claims description 2
• 108091007960 PI3Ks Proteins 0.000 claims description 2
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 claims description 2
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 claims description 2
• 108010017324 STAT3 Transcription Factor Proteins 0.000 claims description 2
• 102100024040 Signal transducer and activator of transcription 3 Human genes 0.000 claims description 2
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 2
• 108010045627 Type I Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Proteins 0.000 claims description 2
• 102000005737 Type I Pituitary Adenylate Cyclase-Activating Polypeptide Receptors Human genes 0.000 claims description 2
• 108090000848 Ubiquitin Proteins 0.000 claims description 2
• 102000044159 Ubiquitin Human genes 0.000 claims description 2
• 208000036142 Viral infection Diseases 0.000 claims description 2
• 230000001800 adrenalinergic effect Effects 0.000 claims description 2
• 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
• 230000008238 biochemical pathway Effects 0.000 claims description 2
• 230000035605 chemotaxis Effects 0.000 claims description 2
• 230000006557 circadian rhythm pathway Effects 0.000 claims description 2
• 239000010432 diamond Substances 0.000 claims description 2
• 229910003460 diamond Inorganic materials 0.000 claims description 2
• 102000015694 estrogen receptors Human genes 0.000 claims description 2
• 108010038795 estrogen receptors Proteins 0.000 claims description 2
• 239000003102 growth factor Substances 0.000 claims description 2
• 229940088597 hormone Drugs 0.000 claims description 2
• 239000005556 hormone Substances 0.000 claims description 2
• 230000008088 immune pathway Effects 0.000 claims description 2
• 238000001727 in vivo Methods 0.000 claims description 2
• 102000006495 integrins Human genes 0.000 claims description 2
• 108010044426 integrins Proteins 0.000 claims description 2
• GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 claims description 2
• 239000002502 liposome Substances 0.000 claims description 2
• 230000003204 osmotic effect Effects 0.000 claims description 2
• 230000003071 parasitic effect Effects 0.000 claims description 2
• BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 claims description 2
• USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 claims description 2
• DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 claims description 2
• 150000003431 steroids Chemical class 0.000 claims description 2
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims description 2
• 230000001131 transforming effect Effects 0.000 claims description 2
• 210000004881 tumor cell Anatomy 0.000 claims description 2
• 239000013598 vector Substances 0.000 claims description 2
• 102000001253 Protein Kinase Human genes 0.000 claims 2
• 108060006633 protein kinase Proteins 0.000 claims 2
• 102100040247 Tumor necrosis factor Human genes 0.000 claims 1
• 230000004048 modification Effects 0.000 abstract description 14
• 238000012986 modification Methods 0.000 abstract description 14
• 235000018102 proteins Nutrition 0.000 description 444
• 239000000523 sample Substances 0.000 description 227
• 238000002493 microarray Methods 0.000 description 45
• 230000003287 optical effect Effects 0.000 description 36
• 239000000126 substance Substances 0.000 description 36
• 229940024606 amino acid Drugs 0.000 description 34
• 235000001014 amino acid Nutrition 0.000 description 33
• 238000003018 immunoassay Methods 0.000 description 29
• 239000012472 biological sample Substances 0.000 description 27
• 230000014509 gene expression Effects 0.000 description 25
• 239000010410 layer Substances 0.000 description 25
• 238000005516 engineering process Methods 0.000 description 24
• 206010028980 Neoplasm Diseases 0.000 description 23
• 230000008569 process Effects 0.000 description 21
• 125000003275 alpha amino acid group Chemical group 0.000 description 20
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 19
• 102100038358 Prostate-specific antigen Human genes 0.000 description 19
• 239000012491 analyte Substances 0.000 description 19
• 239000003446 ligand Substances 0.000 description 19
• 210000001519 tissue Anatomy 0.000 description 19
• 238000006243 chemical reaction Methods 0.000 description 18
• 239000004065 semiconductor Substances 0.000 description 18
• 239000000243 solution Substances 0.000 description 18
• 238000013459 approach Methods 0.000 description 17
• 239000003153 chemical reaction reagent Substances 0.000 description 17
• 239000011521 glass Substances 0.000 description 15
• 230000000875 corresponding effect Effects 0.000 description 14
• 238000012360 testing method Methods 0.000 description 14
• 230000008901 benefit Effects 0.000 description 13
• 239000002070 nanowire Substances 0.000 description 13
• 230000002797 proteolythic effect Effects 0.000 description 13
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
• 102000004506 Blood Proteins Human genes 0.000 description 12
• 108010017384 Blood Proteins Proteins 0.000 description 12
• 201000011510 cancer Diseases 0.000 description 12
• 230000007017 scission Effects 0.000 description 12
• 241000699666 Mus <mouse, genus> Species 0.000 description 11
• 238000003776 cleavage reaction Methods 0.000 description 11
• 238000011161 development Methods 0.000 description 11
• 230000018109 developmental process Effects 0.000 description 11
• 239000010408 film Substances 0.000 description 11
• 210000004408 hybridoma Anatomy 0.000 description 11
• 229910052751 metal Inorganic materials 0.000 description 11
• 239000002184 metal Substances 0.000 description 11
• 230000009870 specific binding Effects 0.000 description 11
• 108091034117 Oligonucleotide Proteins 0.000 description 10
• 238000002372 labelling Methods 0.000 description 10
• CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 10
• 102000053642 Catalytic RNA Human genes 0.000 description 9
• 108090000994 Catalytic RNA Proteins 0.000 description 9
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 9
• UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 9
• 238000010168 coupling process Methods 0.000 description 9
• 208000035475 disorder Diseases 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 229920003023 plastic Polymers 0.000 description 9
• 239000004033 plastic Substances 0.000 description 9
• 239000000047 product Substances 0.000 description 9
• 108091092562 ribozyme Proteins 0.000 description 9
• 238000005406 washing Methods 0.000 description 9
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
• 241000894006 Bacteria Species 0.000 description 8
• 241000700605 Viruses Species 0.000 description 8
• 230000015572 biosynthetic process Effects 0.000 description 8
• 230000008878 coupling Effects 0.000 description 8
• 238000005859 coupling reaction Methods 0.000 description 8
• 230000009260 cross reactivity Effects 0.000 description 8
• 239000004005 microsphere Substances 0.000 description 8
• 239000002159 nanocrystal Substances 0.000 description 8
• 229910052710 silicon Inorganic materials 0.000 description 8
• 239000010703 silicon Substances 0.000 description 8
• 108090000144 Human Proteins Proteins 0.000 description 7
• 102000003839 Human Proteins Human genes 0.000 description 7
• 206010035226 Plasma cell myeloma Diseases 0.000 description 7
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
• 230000007613 environmental effect Effects 0.000 description 7
• 230000002209 hydrophobic effect Effects 0.000 description 7
• 229940027941 immunoglobulin g Drugs 0.000 description 7
• 239000011159 matrix material Substances 0.000 description 7
• 238000005259 measurement Methods 0.000 description 7
• 201000000050 myeloid neoplasm Diseases 0.000 description 7
• 238000003786 synthesis reaction Methods 0.000 description 7
• 229910052984 zinc sulfide Inorganic materials 0.000 description 7
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
• 238000000018 DNA microarray Methods 0.000 description 6
• 108010029485 Protein Isoforms Proteins 0.000 description 6
• 102000001708 Protein Isoforms Human genes 0.000 description 6
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
• 230000003281 allosteric effect Effects 0.000 description 6
• 230000003321 amplification Effects 0.000 description 6
• 239000000090 biomarker Substances 0.000 description 6
• 229960002685 biotin Drugs 0.000 description 6
• 235000020958 biotin Nutrition 0.000 description 6
• 239000011616 biotin Substances 0.000 description 6
• 229940098773 bovine serum albumin Drugs 0.000 description 6
• 230000000295 complement effect Effects 0.000 description 6
• 230000005284 excitation Effects 0.000 description 6
• 238000004949 mass spectrometry Methods 0.000 description 6
• 230000035772 mutation Effects 0.000 description 6
• 238000003199 nucleic acid amplification method Methods 0.000 description 6
• 229920002120 photoresistant polymer Polymers 0.000 description 6
• 229920002401 polyacrylamide Polymers 0.000 description 6
• 210000001138 tear Anatomy 0.000 description 6
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical class C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 6
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
• 241000124008 Mammalia Species 0.000 description 5
• 206010036790 Productive cough Diseases 0.000 description 5
• 239000011230 binding agent Substances 0.000 description 5
• 238000001574 biopsy Methods 0.000 description 5
• 239000013592 cell lysate Substances 0.000 description 5
• 239000011248 coating agent Substances 0.000 description 5
• 238000000576 coating method Methods 0.000 description 5
• 239000000562 conjugate Substances 0.000 description 5
• 239000013068 control sample Substances 0.000 description 5
• 238000013461 design Methods 0.000 description 5
• 230000004927 fusion Effects 0.000 description 5
• 239000000499 gel Substances 0.000 description 5
• 238000013537 high throughput screening Methods 0.000 description 5
• 238000003384 imaging method Methods 0.000 description 5
• 238000004020 luminiscence type Methods 0.000 description 5
• 238000012544 monitoring process Methods 0.000 description 5
• PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 5
• 238000000746 purification Methods 0.000 description 5
• 238000012552 review Methods 0.000 description 5
• 239000007790 solid phase Substances 0.000 description 5
• 210000003802 sputum Anatomy 0.000 description 5
• 208000024794 sputum Diseases 0.000 description 5
• 102000003909 Cyclin E Human genes 0.000 description 4
• 108090000257 Cyclin E Proteins 0.000 description 4
• 108091008102 DNA aptamers Proteins 0.000 description 4
• 239000004593 Epoxy Substances 0.000 description 4
• 102000004889 Interleukin-6 Human genes 0.000 description 4
• 108090001005 Interleukin-6 Proteins 0.000 description 4
• 108091008103 RNA aptamers Proteins 0.000 description 4
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
• 108010090804 Streptavidin Proteins 0.000 description 4
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
• 150000001299 aldehydes Chemical class 0.000 description 4
• 125000000539 amino acid group Chemical group 0.000 description 4
• 238000004422 calculation algorithm Methods 0.000 description 4
• 210000000170 cell membrane Anatomy 0.000 description 4
• 238000000151 deposition Methods 0.000 description 4
• 230000008021 deposition Effects 0.000 description 4
• 239000003599 detergent Substances 0.000 description 4
• 238000002474 experimental method Methods 0.000 description 4
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
• 229910052737 gold Inorganic materials 0.000 description 4
• 239000010931 gold Substances 0.000 description 4
• 208000015181 infectious disease Diseases 0.000 description 4
• 229940100601 interleukin-6 Drugs 0.000 description 4
• 210000004698 lymphocyte Anatomy 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 239000002071 nanotube Substances 0.000 description 4
• 244000052769 pathogen Species 0.000 description 4
• 238000010647 peptide synthesis reaction Methods 0.000 description 4
• YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
• 238000003498 protein array Methods 0.000 description 4
• 230000004850 protein–protein interaction Effects 0.000 description 4
• 230000005855 radiation Effects 0.000 description 4
• 238000003127 radioimmunoassay Methods 0.000 description 4
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
• 238000001228 spectrum Methods 0.000 description 4
• 238000010561 standard procedure Methods 0.000 description 4
• 230000005945 translocation Effects 0.000 description 4
• 108090001008 Avidin Proteins 0.000 description 3
• 102000014914 Carrier Proteins Human genes 0.000 description 3
• 108010078791 Carrier Proteins Proteins 0.000 description 3
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 3
• 102400000401 Latency-associated peptide Human genes 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 206010060862 Prostate cancer Diseases 0.000 description 3
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
• 241000700159 Rattus Species 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• 230000009830 antibody antigen interaction Effects 0.000 description 3
• 230000000890 antigenic effect Effects 0.000 description 3
• 238000002820 assay format Methods 0.000 description 3
• 239000013060 biological fluid Substances 0.000 description 3
• 239000002981 blocking agent Substances 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 210000004899 c-terminal region Anatomy 0.000 description 3
• 239000004202 carbamide Substances 0.000 description 3
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
• 230000008711 chromosomal rearrangement Effects 0.000 description 3
• 210000000349 chromosome Anatomy 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 238000010668 complexation reaction Methods 0.000 description 3
• 229920001577 copolymer Polymers 0.000 description 3
• 239000000539 dimer Substances 0.000 description 3
• 238000010494 dissociation reaction Methods 0.000 description 3
• 230000005593 dissociations Effects 0.000 description 3
• 238000007876 drug discovery Methods 0.000 description 3
• 239000012636 effector Substances 0.000 description 3
• 238000010195 expression analysis Methods 0.000 description 3
• 239000000835 fiber Substances 0.000 description 3
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
• 229920001109 fluorescent polymer Polymers 0.000 description 3
• 235000013305 food Nutrition 0.000 description 3
• 238000001502 gel electrophoresis Methods 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 238000011534 incubation Methods 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 238000011835 investigation Methods 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 230000001404 mediated effect Effects 0.000 description 3
• 108020004999 messenger RNA Proteins 0.000 description 3
• 239000002207 metabolite Substances 0.000 description 3
• 238000010208 microarray analysis Methods 0.000 description 3
• 125000000962 organic group Chemical group 0.000 description 3
• 230000001717 pathogenic effect Effects 0.000 description 3
• 239000008188 pellet Substances 0.000 description 3
• 238000002823 phage display Methods 0.000 description 3
• 210000002307 prostate Anatomy 0.000 description 3
• 230000006337 proteolytic cleavage Effects 0.000 description 3
• 230000002829 reductive effect Effects 0.000 description 3
• 230000000717 retained effect Effects 0.000 description 3
• 238000005096 rolling process Methods 0.000 description 3
• 150000003839 salts Chemical class 0.000 description 3
• 210000000582 semen Anatomy 0.000 description 3
• 239000000377 silicon dioxide Substances 0.000 description 3
• 210000004988 splenocyte Anatomy 0.000 description 3
• 229910052717 sulfur Inorganic materials 0.000 description 3
• 239000010409 thin film Substances 0.000 description 3
• 150000003573 thiols Chemical class 0.000 description 3
• 239000003053 toxin Substances 0.000 description 3
• 102000003390 tumor necrosis factor Human genes 0.000 description 3
• XJPHGGXFBWOHFL-QMMMGPOBSA-N (2s)-2-hydrazinyl-3-(4-hydroxyphenyl)propanoic acid Chemical class NN[C@H](C(O)=O)CC1=CC=C(O)C=C1 XJPHGGXFBWOHFL-QMMMGPOBSA-N 0.000 description 2
• NJYVEMPWNAYQQN-UHFFFAOYSA-N 5-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21 NJYVEMPWNAYQQN-UHFFFAOYSA-N 0.000 description 2
• WQZIDRAQTRIQDX-UHFFFAOYSA-N 6-carboxy-x-rhodamine Chemical compound OC(=O)C1=CC=C(C([O-])=O)C=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 WQZIDRAQTRIQDX-UHFFFAOYSA-N 0.000 description 2
• BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
• 208000030507 AIDS Diseases 0.000 description 2
• 241000193738 Bacillus anthracis Species 0.000 description 2
• 235000006008 Brassica napus var napus Nutrition 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 208000005623 Carcinogenesis Diseases 0.000 description 2
• 208000024172 Cardiovascular disease Diseases 0.000 description 2
• 102000009016 Cholera Toxin Human genes 0.000 description 2
• 108010049048 Cholera Toxin Proteins 0.000 description 2
• 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
• 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
• 108020004638 Circular DNA Proteins 0.000 description 2
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
• 206010061818 Disease progression Diseases 0.000 description 2
• 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 2
• 241001115402 Ebolavirus Species 0.000 description 2
• 241000709661 Enterovirus Species 0.000 description 2
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
• 208000031886 HIV Infections Diseases 0.000 description 2
• 241000711549 Hepacivirus C Species 0.000 description 2
• NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
• 241001502974 Human gammaherpesvirus 8 Species 0.000 description 2
• 241000725303 Human immunodeficiency virus Species 0.000 description 2
• 206010061218 Inflammation Diseases 0.000 description 2
• 102100030856 Myoglobin Human genes 0.000 description 2
• 108010062374 Myoglobin Proteins 0.000 description 2
• 238000005481 NMR spectroscopy Methods 0.000 description 2
• 239000000020 Nitrocellulose Substances 0.000 description 2
• 239000004677 Nylon Substances 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 229930040373 Paraformaldehyde Natural products 0.000 description 2
• 239000004743 Polypropylene Substances 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• 102100035703 Prostatic acid phosphatase Human genes 0.000 description 2
• 239000002262 Schiff base Substances 0.000 description 2
• 150000004753 Schiff bases Chemical class 0.000 description 2
• 108010079723 Shiga Toxin Proteins 0.000 description 2
• 229910052581 Si3N4 Inorganic materials 0.000 description 2
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
• 241000191967 Staphylococcus aureus Species 0.000 description 2
• 206010043376 Tetanus Diseases 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 241000700647 Variola virus Species 0.000 description 2
• 240000008042 Zea mays Species 0.000 description 2
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
• 230000002776 aggregation Effects 0.000 description 2
• 238000004220 aggregation Methods 0.000 description 2
• 239000013566 allergen Substances 0.000 description 2
• 102000013529 alpha-Fetoproteins Human genes 0.000 description 2
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
• 108010027597 alpha-chymotrypsin Proteins 0.000 description 2
• 150000001408 amides Chemical group 0.000 description 2
• 150000001412 amines Chemical group 0.000 description 2
• IVHKZGYFKJRXBD-UHFFFAOYSA-N amino carbamate Chemical compound NOC(N)=O IVHKZGYFKJRXBD-UHFFFAOYSA-N 0.000 description 2
• 125000003277 amino group Chemical group 0.000 description 2
• 150000008064 anhydrides Chemical class 0.000 description 2
• 238000004630 atomic force microscopy Methods 0.000 description 2
• 108010086186 avian pancreatic polypeptide Proteins 0.000 description 2
• 239000002585 base Substances 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 239000012620 biological material Substances 0.000 description 2
• 230000000903 blocking effect Effects 0.000 description 2
• 230000036952 cancer formation Effects 0.000 description 2
• 238000005251 capillar electrophoresis Methods 0.000 description 2
• 238000002045 capillary electrochromatography Methods 0.000 description 2
• 238000001818 capillary gel electrophoresis Methods 0.000 description 2
• 238000005515 capillary zone electrophoresis Methods 0.000 description 2
• 231100000504 carcinogenesis Toxicity 0.000 description 2
• 238000006555 catalytic reaction Methods 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 239000000919 ceramic Substances 0.000 description 2
• 239000003638 chemical reducing agent Substances 0.000 description 2
• 238000004587 chromatography analysis Methods 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 238000002508 contact lithography Methods 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 239000012228 culture supernatant Substances 0.000 description 2
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
• 238000011033 desalting Methods 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• 230000005750 disease progression Effects 0.000 description 2
• 238000000572 ellipsometry Methods 0.000 description 2
• 238000004049 embossing Methods 0.000 description 2
• 238000000295 emission spectrum Methods 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 238000005530 etching Methods 0.000 description 2
• 210000003608 fece Anatomy 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 230000008014 freezing Effects 0.000 description 2
• 238000007710 freezing Methods 0.000 description 2
• 239000001963 growth medium Substances 0.000 description 2
• 108010067006 heat stable toxin (E coli) Proteins 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 238000005286 illumination Methods 0.000 description 2
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
• 238000001597 immobilized metal affinity chromatography Methods 0.000 description 2
• 238000002649 immunization Methods 0.000 description 2
• 230000004054 inflammatory process Effects 0.000 description 2
• 238000005305 interferometry Methods 0.000 description 2
• 230000002427 irreversible effect Effects 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• 238000007726 management method Methods 0.000 description 2
• 230000000873 masking effect Effects 0.000 description 2
• 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 2
• 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
• 208000030159 metabolic disease Diseases 0.000 description 2
• 238000012775 microarray technology Methods 0.000 description 2
• 239000011325 microbead Substances 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 230000003278 mimic effect Effects 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 238000011512 multiplexed immunoassay Methods 0.000 description 2
• 210000003205 muscle Anatomy 0.000 description 2
• 208000010125 myocardial infarction Diseases 0.000 description 2
• 239000002581 neurotoxin Substances 0.000 description 2
• 231100000618 neurotoxin Toxicity 0.000 description 2
• 108010087904 neutravidin Proteins 0.000 description 2
• 229910052759 nickel Inorganic materials 0.000 description 2
• 229920001220 nitrocellulos Polymers 0.000 description 2
• 230000009871 nonspecific binding Effects 0.000 description 2
• 108091008104 nucleic acid aptamers Proteins 0.000 description 2
• 229920001778 nylon Polymers 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 210000003463 organelle Anatomy 0.000 description 2
• BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 2
• 230000000737 periodic effect Effects 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• 238000000206 photolithography Methods 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 239000004926 polymethyl methacrylate Substances 0.000 description 2
• 229920006324 polyoxymethylene Polymers 0.000 description 2
• 229920001155 polypropylene Polymers 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• 230000001323 posttranslational effect Effects 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 230000035935 pregnancy Effects 0.000 description 2
• 238000002203 pretreatment Methods 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 238000007639 printing Methods 0.000 description 2
• 108010043671 prostatic acid phosphatase Proteins 0.000 description 2
• 230000004952 protein activity Effects 0.000 description 2
• 238000000159 protein binding assay Methods 0.000 description 2
• 238000000734 protein sequencing Methods 0.000 description 2
• 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
• 238000006862 quantum yield reaction Methods 0.000 description 2
• 238000010791 quenching Methods 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 238000009877 rendering Methods 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 238000004366 reverse phase liquid chromatography Methods 0.000 description 2
• 238000003118 sandwich ELISA Methods 0.000 description 2
• FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
• CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
• 239000004054 semiconductor nanocrystal Substances 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• 235000012239 silicon dioxide Nutrition 0.000 description 2
• HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
• 229910052709 silver Inorganic materials 0.000 description 2
• 239000004332 silver Substances 0.000 description 2
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
• 238000010532 solid phase synthesis reaction Methods 0.000 description 2
• 238000001179 sorption measurement Methods 0.000 description 2
• 230000003595 spectral effect Effects 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 125000004434 sulfur atom Chemical group 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 125000003396 thiol group Chemical group [H]S* 0.000 description 2
• QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 2
• 239000004408 titanium dioxide Substances 0.000 description 2
• 230000001960 triggered effect Effects 0.000 description 2
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
• 229920002554 vinyl polymer Polymers 0.000 description 2
• ZJIFDEVVTPEXDL-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) hydrogen carbonate Chemical compound OC(=O)ON1C(=O)CCC1=O ZJIFDEVVTPEXDL-UHFFFAOYSA-N 0.000 description 1
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
• MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
• FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 1
• GVJXGCIPWAVXJP-UHFFFAOYSA-N 2,5-dioxo-1-oxoniopyrrolidine-3-sulfonate Chemical compound ON1C(=O)CC(S(O)(=O)=O)C1=O GVJXGCIPWAVXJP-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• SUGXUUGGLDCZKB-UHFFFAOYSA-N 3,4-dichloroisocoumarin Chemical compound C1=CC=C2C(Cl)=C(Cl)OC(=O)C2=C1 SUGXUUGGLDCZKB-UHFFFAOYSA-N 0.000 description 1
• TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
• TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
• 206010000830 Acute leukaemia Diseases 0.000 description 1
• 206010048998 Acute phase reaction Diseases 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
• 108010082126 Alanine transaminase Proteins 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 208000037259 Amyloid Plaque Diseases 0.000 description 1
• 241000212977 Andira Species 0.000 description 1
• 102000000412 Annexin Human genes 0.000 description 1
• 108050008874 Annexin Proteins 0.000 description 1
• 108090000672 Annexin A5 Proteins 0.000 description 1
• 102000004121 Annexin A5 Human genes 0.000 description 1
• 108010032595 Antibody Binding Sites Proteins 0.000 description 1
• 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
• 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
• 102000018616 Apolipoproteins B Human genes 0.000 description 1
• 108010027006 Apolipoproteins B Proteins 0.000 description 1
• 108010031480 Artificial Receptors Proteins 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
• 108030002081 Aspartate transaminases Proteins 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
• 108091005658 Basic proteases Proteins 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
• 208000020084 Bone disease Diseases 0.000 description 1
• 108030001720 Bontoxilysin Proteins 0.000 description 1
• 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
• 240000002791 Brassica napus Species 0.000 description 1
• 240000000385 Brassica napus var. napus Species 0.000 description 1
• 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
• 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
• 241001598984 Bromius obscurus Species 0.000 description 1
• 101000741929 Caenorhabditis elegans Serine/threonine-protein phosphatase 2A catalytic subunit Proteins 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 108010076119 Caseins Proteins 0.000 description 1
• 108090000397 Caspase 3 Proteins 0.000 description 1
• 102000004018 Caspase 6 Human genes 0.000 description 1
• 108090000425 Caspase 6 Proteins 0.000 description 1
• 108090000567 Caspase 7 Proteins 0.000 description 1
• 102100032616 Caspase-2 Human genes 0.000 description 1
• 108090000552 Caspase-2 Proteins 0.000 description 1
• 102100029855 Caspase-3 Human genes 0.000 description 1
• 102100025597 Caspase-4 Human genes 0.000 description 1
• 101710090338 Caspase-4 Proteins 0.000 description 1
• 102100038916 Caspase-5 Human genes 0.000 description 1
• 101710090333 Caspase-5 Proteins 0.000 description 1
• 102100038902 Caspase-7 Human genes 0.000 description 1
• 102100026548 Caspase-8 Human genes 0.000 description 1
• 108090000538 Caspase-8 Proteins 0.000 description 1
• 229910004613 CdTe Inorganic materials 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 241000242722 Cestoda Species 0.000 description 1
• 241000606161 Chlamydia Species 0.000 description 1
• 208000006332 Choriocarcinoma Diseases 0.000 description 1
• 102100026735 Coagulation factor VIII Human genes 0.000 description 1
• 206010053567 Coagulopathies Diseases 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• 229920000742 Cotton Polymers 0.000 description 1
• 241001445332 Coxiella <snail> Species 0.000 description 1
• 201000003808 Cystic echinococcosis Diseases 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 230000004544 DNA amplification Effects 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 102100035784 Decorin Human genes 0.000 description 1
• 108090000738 Decorin Proteins 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 101100085205 Dictyostelium discoideum ptpB gene Proteins 0.000 description 1
• 208000035859 Drug effect increased Diseases 0.000 description 1
• 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 241000244170 Echinococcus granulosus Species 0.000 description 1
• 241000244163 Echinococcus multilocularis Species 0.000 description 1
• 241000244162 Echinococcus oligarthrus Species 0.000 description 1
• 241000244165 Echinococcus vogeli Species 0.000 description 1
• 241001466953 Echovirus Species 0.000 description 1
• 241000991587 Enterovirus C Species 0.000 description 1
• 101710181478 Envelope glycoprotein GP350 Proteins 0.000 description 1
• 241000588722 Escherichia Species 0.000 description 1
• 108010019957 Escherichia coli periplasmic proteinase Proteins 0.000 description 1
• 208000006168 Ewing Sarcoma Diseases 0.000 description 1
• 241000714165 Feline leukemia virus Species 0.000 description 1
• 102100031509 Fibrillin-1 Human genes 0.000 description 1
• 108010030229 Fibrillin-1 Proteins 0.000 description 1
• 102100031510 Fibrillin-2 Human genes 0.000 description 1
• 108010030242 Fibrillin-2 Proteins 0.000 description 1
• 102000016359 Fibronectins Human genes 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 239000004606 Fillers/Extenders Substances 0.000 description 1
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 108010051815 Glutamyl endopeptidase Proteins 0.000 description 1
• 108010070675 Glutathione transferase Proteins 0.000 description 1
• 244000068988 Glycine max Species 0.000 description 1
• 235000010469 Glycine max Nutrition 0.000 description 1
• 244000299507 Gossypium hirsutum Species 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 108010010369 HIV Protease Proteins 0.000 description 1
• 208000037357 HIV infectious disease Diseases 0.000 description 1
• 244000020551 Helianthus annuus Species 0.000 description 1
• 235000003222 Helianthus annuus Nutrition 0.000 description 1
• 241000590002 Helicobacter pylori Species 0.000 description 1
• 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
• 102000006947 Histones Human genes 0.000 description 1
• 108010033040 Histones Proteins 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
• 101000877727 Homo sapiens Forkhead box protein O1 Proteins 0.000 description 1
• 101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 1
• 101001024605 Homo sapiens Next to BRCA1 gene 1 protein Proteins 0.000 description 1
• 101100518996 Homo sapiens PAX3 gene Proteins 0.000 description 1
• 230000010740 Hormone Receptor Interactions Effects 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 108010058683 Immobilized Proteins Proteins 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
• 108010055717 JNK Mitogen-Activated Protein Kinases Proteins 0.000 description 1
• 102000019145 JUN kinase activity proteins Human genes 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• 238000012773 Laboratory assay Methods 0.000 description 1
• 241000712902 Lassa mammarenavirus Species 0.000 description 1
• 101800001155 Latency-associated peptide Proteins 0.000 description 1
• 102000008121 Latent TGF-beta Binding Proteins Human genes 0.000 description 1
• 108010049807 Latent TGF-beta Binding Proteins Proteins 0.000 description 1
• 241000589248 Legionella Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 241001374849 Liparis atlanticus Species 0.000 description 1
• 241000186781 Listeria Species 0.000 description 1
• 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
• 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
• 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
• 208000002720 Malnutrition Diseases 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
• 240000004658 Medicago sativa Species 0.000 description 1
• 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 102100023174 Methionine aminopeptidase 2 Human genes 0.000 description 1
• 108090000192 Methionyl aminopeptidases Proteins 0.000 description 1
• 238000006845 Michael addition reaction Methods 0.000 description 1
• 241000237852 Mollusca Species 0.000 description 1
• 102100023123 Mucin-16 Human genes 0.000 description 1
• 108010085220 Multiprotein Complexes Proteins 0.000 description 1
• 102000007474 Multiprotein Complexes Human genes 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 208000029578 Muscle disease Diseases 0.000 description 1
• 241000204031 Mycoplasma Species 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 101100208473 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) lcm-2 gene Proteins 0.000 description 1
• 241000714209 Norwalk virus Species 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• ZMUANTVDGHVAHS-UHFFFAOYSA-N OBOB(O)C1=CC=CC=C1 Chemical compound OBOB(O)C1=CC=CC=C1 ZMUANTVDGHVAHS-UHFFFAOYSA-N 0.000 description 1
• BXEFQPCKQSTMKA-UHFFFAOYSA-N OC(=O)C=[N+]=[N-] Chemical compound OC(=O)C=[N+]=[N-] BXEFQPCKQSTMKA-UHFFFAOYSA-N 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 240000007594 Oryza sativa Species 0.000 description 1
• 235000007164 Oryza sativa Nutrition 0.000 description 1
• 108010058846 Ovalbumin Proteins 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 101150063139 PTP2 gene Proteins 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 108010043958 Peptoids Proteins 0.000 description 1
• 229920005439 Perspex® Polymers 0.000 description 1
• 102100024242 Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 Human genes 0.000 description 1
• 101710174325 Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 Proteins 0.000 description 1
• 108010001441 Phosphopeptides Proteins 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 208000002151 Pleural effusion Diseases 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 229920001665 Poly-4-vinylphenol Polymers 0.000 description 1
• 239000004952 Polyamide Substances 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 229920002873 Polyethylenimine Polymers 0.000 description 1
• 239000004642 Polyimide Substances 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 101710118538 Protease Proteins 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 108010076504 Protein Sorting Signals Proteins 0.000 description 1
• 241000125945 Protoparvovirus Species 0.000 description 1
• 241000221300 Puccinia Species 0.000 description 1
• 230000010799 Receptor Interactions Effects 0.000 description 1
• 241000725643 Respiratory syncytial virus Species 0.000 description 1
• 241000702670 Rotavirus Species 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 108010077895 Sarcosine Proteins 0.000 description 1
• 108010071390 Serum Albumin Proteins 0.000 description 1
• 102000007562 Serum Albumin Human genes 0.000 description 1
• 102000034755 Sex Hormone-Binding Globulin Human genes 0.000 description 1
• 108010089417 Sex Hormone-Binding Globulin Proteins 0.000 description 1
• 229910008051 Si-OH Inorganic materials 0.000 description 1
• BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
• 241000713311 Simian immunodeficiency virus Species 0.000 description 1
• 241000710960 Sindbis virus Species 0.000 description 1
• 229910006358 Si—OH Inorganic materials 0.000 description 1
• 240000003768 Solanum lycopersicum Species 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 241000194017 Streptococcus Species 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 108091008874 T cell receptors Proteins 0.000 description 1
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
• 102000007453 TGF-beta Superfamily Proteins Human genes 0.000 description 1
• 108010085004 TGF-beta Superfamily Proteins Proteins 0.000 description 1
• 239000004809 Teflon Substances 0.000 description 1
• 229920006362 Teflon® Polymers 0.000 description 1
• NYTOUQBROMCLBJ-UHFFFAOYSA-N Tetranitromethane Chemical compound [O-][N+](=O)C([N+]([O-])=O)([N+]([O-])=O)[N+]([O-])=O NYTOUQBROMCLBJ-UHFFFAOYSA-N 0.000 description 1
• 102100036407 Thioredoxin Human genes 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 206010070863 Toxicity to various agents Diseases 0.000 description 1
• 102100033663 Transforming growth factor beta receptor type 3 Human genes 0.000 description 1
• 206010052779 Transplant rejections Diseases 0.000 description 1
• 241000209140 Triticum Species 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 102000004903 Troponin Human genes 0.000 description 1
• 108090001027 Troponin Proteins 0.000 description 1
• 241000223105 Trypanosoma brucei Species 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 241000710886 West Nile virus Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
• 239000005083 Zinc sulfide Substances 0.000 description 1
• 230000005856 abnormality Effects 0.000 description 1
• CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000004658 acute-phase response Effects 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 108060000200 adenylate cyclase Proteins 0.000 description 1
• 102000030621 adenylate cyclase Human genes 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 238000002299 affinity electrophoresis Methods 0.000 description 1
• 230000009824 affinity maturation Effects 0.000 description 1
• 238000003314 affinity selection Methods 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 125000003172 aldehyde group Chemical group 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 108010004469 allophycocyanin Proteins 0.000 description 1
• 239000000956 alloy Substances 0.000 description 1
• 229910045601 alloy Inorganic materials 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 206010065867 alveolar rhabdomyosarcoma Diseases 0.000 description 1
• 229960003896 aminopterin Drugs 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 239000001166 ammonium sulphate Substances 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 239000003098 androgen Substances 0.000 description 1
• 229940030486 androgens Drugs 0.000 description 1
• 230000003556 anti-epileptic effect Effects 0.000 description 1
• 230000002788 anti-peptide Effects 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 210000000628 antibody-producing cell Anatomy 0.000 description 1
• 239000001961 anticonvulsive agent Substances 0.000 description 1
• 229960003965 antiepileptics Drugs 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 244000309743 astrovirus Species 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 108010041102 azocasein Proteins 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 108700041737 bcl-2 Genes Proteins 0.000 description 1
• RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
• 239000012965 benzophenone Substances 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 108010079292 betaglycan Proteins 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 238000010256 biochemical assay Methods 0.000 description 1
• 239000003150 biochemical marker Substances 0.000 description 1
• 239000003124 biologic agent Substances 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 230000008236 biological pathway Effects 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 229920001222 biopolymer Polymers 0.000 description 1
• 230000002051 biphasic effect Effects 0.000 description 1
• 229920001400 block copolymer Polymers 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• 238000009534 blood test Methods 0.000 description 1
• 238000010504 bond cleavage reaction Methods 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 125000001246 bromo group Chemical group Br* 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 229910052793 cadmium Inorganic materials 0.000 description 1
• 208000035269 cancer or benign tumor Diseases 0.000 description 1
• 230000000711 cancerogenic effect Effects 0.000 description 1
• 238000000533 capillary isoelectric focusing Methods 0.000 description 1
• KDJVUTSOHYQCDQ-UHFFFAOYSA-N carbamic acid;1h-imidazole Chemical compound NC([O-])=O.[NH2+]1C=CN=C1 KDJVUTSOHYQCDQ-UHFFFAOYSA-N 0.000 description 1
• 150000001718 carbodiimides Chemical class 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 150000007942 carboxylates Chemical group 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
• 231100000357 carcinogen Toxicity 0.000 description 1
• 239000003183 carcinogenic agent Substances 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• 239000005018 casein Substances 0.000 description 1
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000004640 cellular pathway Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 235000013339 cereals Nutrition 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 239000003541 chymotrypsin inhibitor Substances 0.000 description 1
• 238000003759 clinical diagnosis Methods 0.000 description 1
• 239000000084 colloidal system Substances 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 230000009850 completed effect Effects 0.000 description 1
• 230000009918 complex formation Effects 0.000 description 1
• 238000010205 computational analysis Methods 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 230000001143 conditioned effect Effects 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 230000002596 correlated effect Effects 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 108010014562 cytotoxic necrotizing factor type 1 Proteins 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 239000007857 degradation product Substances 0.000 description 1
• 238000003795 desorption Methods 0.000 description 1
• 229940119743 dextran 70 Drugs 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 229940079919 digestives enzyme preparation Drugs 0.000 description 1
• 239000012470 diluted sample Substances 0.000 description 1
• 239000004205 dimethyl polysiloxane Substances 0.000 description 1
• 238000004821 distillation Methods 0.000 description 1
• 125000002228 disulfide group Chemical group 0.000 description 1
• 150000004662 dithiols Chemical group 0.000 description 1
• 229940000406 drug candidate Drugs 0.000 description 1
• 238000009509 drug development Methods 0.000 description 1
• 230000000857 drug effect Effects 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 238000005274 electrospray deposition Methods 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 239000003256 environmental substance Substances 0.000 description 1
• 231100000317 environmental toxin Toxicity 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 230000009144 enzymatic modification Effects 0.000 description 1
• 238000006911 enzymatic reaction Methods 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 150000002148 esters Chemical group 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 230000006126 farnesylation Effects 0.000 description 1
• 235000013861 fat-free Nutrition 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 102000013361 fetuin Human genes 0.000 description 1
• 108060002885 fetuin Proteins 0.000 description 1
• 238000009501 film coating Methods 0.000 description 1
• 239000005357 flat glass Substances 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 238000000799 fluorescence microscopy Methods 0.000 description 1
• 238000002875 fluorescence polarization Methods 0.000 description 1
• XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical group FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 201000003444 follicular lymphoma Diseases 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 238000007306 functionalization reaction Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 230000006127 geranylation Effects 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
• 150000002343 gold Chemical class 0.000 description 1
• 238000000892 gravimetry Methods 0.000 description 1
• 229960004198 guanidine Drugs 0.000 description 1
• PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
• 125000005179 haloacetyl group Chemical group 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 210000002064 heart cell Anatomy 0.000 description 1
• 229940037467 helicobacter pylori Drugs 0.000 description 1
• IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
• 229960001340 histamine Drugs 0.000 description 1
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
• 230000003054 hormonal effect Effects 0.000 description 1
• 238000002657 hormone replacement therapy Methods 0.000 description 1
• 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
• 150000007857 hydrazones Chemical class 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• 150000002460 imidazoles Chemical class 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 238000003365 immunocytochemistry Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 238000001114 immunoprecipitation Methods 0.000 description 1
• 230000003308 immunostimulating effect Effects 0.000 description 1
• 238000000126 in silico method Methods 0.000 description 1
• 238000011503 in vivo imaging Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 238000007373 indentation Methods 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 238000012482 interaction analysis Methods 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
• 238000004255 ion exchange chromatography Methods 0.000 description 1
• 230000001788 irregular Effects 0.000 description 1
• 208000028867 ischemia Diseases 0.000 description 1
• 239000012948 isocyanate Substances 0.000 description 1
• 150000002513 isocyanates Chemical class 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 150000002540 isothiocyanates Chemical class 0.000 description 1
• 230000000155 isotopic effect Effects 0.000 description 1
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 210000005229 liver cell Anatomy 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 230000000527 lymphocytic effect Effects 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 229920002521 macromolecule Polymers 0.000 description 1
• 235000009973 maize Nutrition 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 230000001071 malnutrition Effects 0.000 description 1
• 235000000824 malnutrition Nutrition 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• 238000000813 microcontact printing Methods 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 230000000897 modulatory effect Effects 0.000 description 1
• 230000009149 molecular binding Effects 0.000 description 1
• 230000004001 molecular interaction Effects 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 230000008450 motivation Effects 0.000 description 1
• 210000003097 mucus Anatomy 0.000 description 1
• 238000010235 multi-parametric assay Methods 0.000 description 1
• 238000007837 multiplex assay Methods 0.000 description 1
• 210000000663 muscle cell Anatomy 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 208000025113 myeloid leukemia Diseases 0.000 description 1
• 229940105132 myristate Drugs 0.000 description 1
• LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
• YFCUZWYIPBUQBD-ZOWNYOTGSA-N n-[(3s)-7-amino-1-chloro-2-oxoheptan-3-yl]-4-methylbenzenesulfonamide;hydron;chloride Chemical compound Cl.CC1=CC=C(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)C=C1 YFCUZWYIPBUQBD-ZOWNYOTGSA-N 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 230000002956 necrotizing effect Effects 0.000 description 1
• 210000005170 neoplastic cell Anatomy 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 210000000944 nerve tissue Anatomy 0.000 description 1
• 208000029986 neuroepithelioma Diseases 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 238000006396 nitration reaction Methods 0.000 description 1
• 150000002825 nitriles Chemical group 0.000 description 1
• MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 239000000101 novel biomarker Substances 0.000 description 1
• 208000015380 nutritional deficiency disease Diseases 0.000 description 1
• 238000006384 oligomerization reaction Methods 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 229940092253 ovalbumin Drugs 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 239000000813 peptide hormone Substances 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 239000000575 pesticide Substances 0.000 description 1
• 239000008177 pharmaceutical agent Substances 0.000 description 1
• 230000002974 pharmacogenomic effect Effects 0.000 description 1
• 102000036213 phospholipid binding proteins Human genes 0.000 description 1
• 108091011000 phospholipid binding proteins Proteins 0.000 description 1
• 150000008300 phosphoramidites Chemical class 0.000 description 1
• LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000002985 plastic film Substances 0.000 description 1
• 229920006255 plastic film Polymers 0.000 description 1
• 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
• 229920000747 poly(lactic acid) Polymers 0.000 description 1
• 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 239000004417 polycarbonate Substances 0.000 description 1
• 229920000515 polycarbonate Polymers 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
• 229920001721 polyimide Polymers 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 102000054765 polymorphisms of proteins Human genes 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 239000004800 polyvinyl chloride Substances 0.000 description 1
• 229920000915 polyvinyl chloride Polymers 0.000 description 1
• 229910021426 porous silicon Inorganic materials 0.000 description 1
• ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
• 229940116357 potassium thiocyanate Drugs 0.000 description 1
• 238000010944 pre-mature reactiony Methods 0.000 description 1
• 230000001376 precipitating effect Effects 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 238000002953 preparative HPLC Methods 0.000 description 1
• 238000004321 preservation Methods 0.000 description 1
• 150000003141 primary amines Chemical class 0.000 description 1
• 238000012913 prioritisation Methods 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000001902 propagating effect Effects 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 230000004845 protein aggregation Effects 0.000 description 1
• 238000002818 protein evolution Methods 0.000 description 1
• 230000004853 protein function Effects 0.000 description 1
• 230000006920 protein precipitation Effects 0.000 description 1
• 230000029983 protein stabilization Effects 0.000 description 1
• 235000021251 pulses Nutrition 0.000 description 1
• 239000010453 quartz Substances 0.000 description 1
• 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
• 230000000171 quenching effect Effects 0.000 description 1
• 230000005258 radioactive decay Effects 0.000 description 1
• 239000000376 reactant Substances 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 238000002310 reflectometry Methods 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000001209 resonance light scattering Methods 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000002702 ribosome display Methods 0.000 description 1
• 235000009566 rice Nutrition 0.000 description 1
• 239000005060 rubber Substances 0.000 description 1
• HBROZNQEVUILML-UHFFFAOYSA-N salicylhydroxamic acid Chemical compound ONC(=O)C1=CC=CC=C1O HBROZNQEVUILML-UHFFFAOYSA-N 0.000 description 1
• 238000002133 sample digestion Methods 0.000 description 1
• 239000012488 sample solution Substances 0.000 description 1
• 229940043230 sarcosine Drugs 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 229930195734 saturated hydrocarbon Natural products 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 238000011896 sensitive detection Methods 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 231100000004 severe toxicity Toxicity 0.000 description 1
• 229910000077 silane Inorganic materials 0.000 description 1
• 238000001542 size-exclusion chromatography Methods 0.000 description 1
• JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
• 239000002689 soil Substances 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 238000005063 solubilization Methods 0.000 description 1
• 230000007928 solubilization Effects 0.000 description 1
• 238000000638 solvent extraction Methods 0.000 description 1
• 210000001082 somatic cell Anatomy 0.000 description 1
• 238000004611 spectroscopical analysis Methods 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
• 239000002344 surface layer Substances 0.000 description 1
• 238000001847 surface plasmon resonance imaging Methods 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 208000006379 syphilis Diseases 0.000 description 1
• 230000009897 systematic effect Effects 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 229910001936 tantalum oxide Inorganic materials 0.000 description 1
• 239000012085 test solution Substances 0.000 description 1
• TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
• ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
• 238000011285 therapeutic regimen Methods 0.000 description 1
• 230000008646 thermal stress Effects 0.000 description 1
• 150000003568 thioethers Chemical class 0.000 description 1
• ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
• 108060008226 thioredoxin Proteins 0.000 description 1
• 229940094937 thioredoxin Drugs 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 239000010936 titanium Substances 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000027 toxicology Toxicity 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000013519 translation Methods 0.000 description 1
• 238000002834 transmittance Methods 0.000 description 1
• YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
• 108010036927 trypsin-like serine protease Proteins 0.000 description 1
• 230000001810 trypsinlike Effects 0.000 description 1
• 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 230000009452 underexpressoin Effects 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 238000012795 verification Methods 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 239000002023 wood Substances 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1